A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HSK21542 Injection for Postoperative Analgesia of Subjects Undergoing Elective Laparoscopic Surgery Under General Anesthesia
Latest Information Update: 23 Feb 2023
At a glance
- Drugs HSK 21542 (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Haisco Pharmaceutical Group
- 25 May 2022 Status changed from not yet recruiting to completed.
- 09 Feb 2021 New trial record